alantolactone has been researched along with Disease Models, Animal in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Dou, W; Han, M; Luo, X; Ren, G; Ren, Y; Sun, A; Wang, Z; Yu, Z; Yue, B; Zhang, J | 1 |
| Cheng, W; Feng, L; Hou, Q; Huo, X; Lan, Y; Ma, X; Sun, C; Sun, D; Tian, X; Wang, C; Wang, X; Wang, Y; Xing, J; Yu, Z; Zhang, B | 1 |
| Huang, L; Mi, J; Tong, J; Wu, Y; Xu, X; Yan, H; Zhang, C; Zhang, Z | 1 |
| Alonso Blasi, N; Benezra, C; Fraginals, R; Lepoittevin, JP | 1 |
5 other study(ies) available for alantolactone and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Activation of PXR by alantolactone ameliorates DSS-induced experimental colitis via suppressing NF-κB signaling pathway.
Topics: Animals; Anti-Inflammatory Agents; Colitis; Dextran Sulfate; Disease Models, Animal; Fluorescent Antibody Technique; Gene Knockdown Techniques; Humans; Lactones; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; NF-kappa B; Pregnane X Receptor; Sesquiterpenes, Eudesmane; Signal Transduction | 2019 |
Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Biomarkers; Blood-Brain Barrier; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Cytochromes c; Disease Models, Animal; Dose-Response Relationship, Drug; E1A-Associated p300 Protein; Humans; I-kappa B Kinase; Lactones; Male; Mice; Models, Biological; Molecular Conformation; NF-kappa B; Promoter Regions, Genetic; Protein Binding; Rats; Sesquiterpenes, Eudesmane; Signal Transduction | 2017 |
Targeting non-oncogene ROS pathway by alantolactone in B cell acute lymphoblastic leukemia cells.
Topics: Animals; Apoptosis; B-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Female; Humans; Lactones; Male; Mice; Mice, Inbred NOD; Mice, SCID; Mitochondria; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Cell Culture; Reactive Oxygen Species; Sesquiterpenes, Eudesmane | 2019 |
A murine in vitro model of allergic contact dermatitis to sesquiterpene alpha-methylene-gamma-butyrolactones.
Topics: Animals; Cross Reactions; Dermatitis, Allergic Contact; Disease Models, Animal; In Vitro Techniques; Lactones; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Sesquiterpenes; Sesquiterpenes, Eudesmane; Species Specificity | 1992 |